CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Twist Bioscience Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Twist Bioscience Corp
681 Gateway Blvd.
Phone: (408) 410-0105p:408 410-0105 SOUTH SAN FRANCISCO, CA  94080  United States Ticker: TWSTTWST
Business Summary
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20249/30/2024YesYes--Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer & Director Emily M.Leproust
Chairman of the Board, Chief Executive Officer Emily M.Leproust 51 10/25/2022 4/1/2013
Chief Operating Officer & Director WilliamBanyai
26 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Igenomx International Genomics Corporation 5858 Dryden Pl Carlsbad CA United States

Business Names
Business Name
AbX Biologics, Inc
Genome Compiler Corporation
Igenomx International Genomics Corporation
7 additional Business Names available in full report.

General Information
Number of Employees: 923 (As of 9/30/2024)
Outstanding Shares: 59,356,440 (As of 11/13/2024)
Shareholders: 50
Stock Exchange: NASD
Federal Tax Id: 462058888
Fax Number: (302) 531-3150


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024